Immuneering CorporationIMRXNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-55.9%
5Y CAGR-12.5%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-55.9%/yr
Annual compound
5Y CAGR
-12.5%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 7.59% |
| 2024 | -4.07% |
| 2023 | 7.39% |
| 2022 | 88.67% |
| 2021 | 165.98% |
| 2020 | 14.81% |
| 2019 | 0.00% |